{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:41:03Z","timestamp":1793209263616,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070226"],"award-info":[{"award-number":["82070226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115405","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:11:02Z","timestamp":1758600662000},"page":"115405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Piwi-interacting RNA-823 promotes cell growth and chemoresistance by stimulating the TGF-\u03b21-mediated AKT\/ERK pathway in multiple myeloma"],"prefix":"10.1016","volume":"166","author":[{"given":"Wei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115405_bb0005","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10.1016\/j.intimp.2025.115405_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: A unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115405_bb0015","first-page":"58","volume":"19","author":"c. Medical Masterclass, J. Firth","year":"2019","journal-title":"Haematology: multiple myeloma, Clin Med (Lond)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115405_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41576-018-0073-3","article-title":"PIWI-interacting RNAs: small RNAs with big functions","volume":"20","author":"Ozata","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"26","key":"10.1016\/j.intimp.2025.115405_bb0025","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/s41388-019-0788-4","article-title":"piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2025.115405_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/genes12040598","article-title":"piRNA-823 is a unique potential diagnostic non-invasive biomarker in colorectal Cancer patients","volume":"12","author":"Sabbah","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2025.115405_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641052","article-title":"piRNA-823 is involved in Cancer stem cell regulation through altering DNA methylation in association with luminal breast Cancer","volume":"9","author":"Ding","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115405_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/leu.2014.135","article-title":"piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma","volume":"29","author":"Yan","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.intimp.2025.115405_bb0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4143\/crt.2015.209","article-title":"Dexamethasone inhibits TGF-\u03b21-induced cell migration by regulating the ERK and AKT pathways in human Colon Cancer cells via CYR61","volume":"48","author":"Han","year":"2016","journal-title":"Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.intimp.2025.115405_bb0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.oraloncology.2012.01.012","article-title":"CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.intimp.2025.115405_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.468","article-title":"Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation","volume":"5","author":"Kao","year":"2014","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.intimp.2025.115405_bb0060","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1182\/blood-2010-02-267344","article-title":"Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications","volume":"117","author":"Jakubikova","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.intimp.2025.115405_bb0065","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1158\/0008-5472.CAN-16-3011","article-title":"Loss of FAM46C promotes cell survival in myeloma","volume":"77","author":"Zhu","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115405_bb0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/leu.2015.289","article-title":"Halting pro-survival autophagy by TGFbeta inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients","volume":"30","author":"Frassanito","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.intimp.2025.115405_bb0075","first-page":"866","article-title":"Chinese myeloma committee-Chinese hematology, [the guidelines for the diagnosis and management of multiple myeloma in China (2017 revision)]","volume":"56","author":"A. Chinese Hematology, H. Chinese Society of, A","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.intimp.2025.115405_bb0080","doi-asserted-by":"crossref","unstructured":"X. Wei, Y. Feng, Y. Fu, et al., miR-100-5p Is Upregulated in Multiple Myeloma and Involves in the Pathogenesis of Multiple Myeloma through Targeting MTMR3, Hematology (Amsterdam, Netherlands) vol. 28(1) (2023) 2196857.","DOI":"10.1080\/16078454.2023.2196857"},{"issue":"6","key":"10.1016\/j.intimp.2025.115405_bb0085","first-page":"805","article-title":"The mRNA expression and regulation of glucocorticoid receptor isoforms associated with response of multiple myeloma treated with a glucocorticoids-dependent regimen of dexamethasone","volume":"51","author":"Guan","year":"2021","journal-title":"Bortezomib and Thalidomide, Annals of clinical and laboratory science"},{"issue":"4","key":"10.1016\/j.intimp.2025.115405_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874467212666190306165703","article-title":"In-vitro pre-treatment of Cancer cells with TGF-beta1: a novel approach of tail vein lung Cancer metastasis mouse model for anti-metastatic studies","volume":"12","author":"Khan","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115405_bb0095","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/cas.13300","article-title":"piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1","volume":"108","author":"Yin","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115405_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-019-1011-5","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation","volume":"18","author":"Ai","year":"2019","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115405_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020448","article-title":"Potential role of microRNAs in inducing drug resistance in patients with multiple myeloma","volume":"10","author":"Allegra","year":"2021","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.intimp.2025.115405_bb0110","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.2021014749","article-title":"Exosomes in multiple myeloma: from bench to bedside","volume":"140","author":"Menu","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.115405_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-018-0731-5","article-title":"Metformin induces autophagy and G0\/G1 phase cell cycle arrest in myeloma by targeting the AMPK\/mTORC1 and mTORC2 pathways","volume":"37","author":"Wang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115405_bb0120","first-page":"713","article-title":"Effects of DNMT1 gene silencing on methylation of SOCS-1 gene in myeloma cells","volume":"23","author":"Wang","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.intimp.2025.115405_bb0125","first-page":"403","article-title":"Effect of shRNA-mediated silencing of BDNF gene on VEGF expression of RPMI8226 cells","volume":"36","author":"Huang","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.intimp.2025.115405_bb0130","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/cam4.455","article-title":"Circulating TGF-beta1 and VEGF and risk of cancer among liver transplant recipients","volume":"4","author":"Engels","year":"2015","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115405_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-020-01235-0","article-title":"Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p\/miR-506-3p- TGF-beta1 axis","volume":"19","author":"Shang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.115405_bb0140","doi-asserted-by":"crossref","first-page":"9151","DOI":"10.12659\/MSM.914222","article-title":"The combination of piR-823 and eukaryotic initiation factor 3 B (EIF3B) activates hepatic stellate cells via upregulating TGF-beta1 in liver Fibrogenesis","volume":"24","author":"Tang","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.intimp.2025.115405_bb0145","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4143\/crt.2015.209","article-title":"Dexamethasone inhibits TGF-beta1-induced cell migration by regulating the ERK and AKT pathways in human Colon Cancer cells via CYR61","volume":"48","author":"Han","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.intimp.2025.115405_bb0150","first-page":"526","article-title":"Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt","volume":"47","author":"Wei","year":"2008","journal-title":"ERK, and NF-kappaB-dependent pathway in human breast cancer cells, Mol Carcinog"},{"key":"10.1016\/j.intimp.2025.115405_bb0155","first-page":"1029","article-title":"Bortezomib inhibits proliferation, migration, and TGF-beta1-induced epithelial-mesenchymal transition of RPE cells","volume":"23","author":"Moon","year":"2017","journal-title":"Mol. Vis."},{"issue":"8","key":"10.1016\/j.intimp.2025.115405_bb0160","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.18632\/aging.102996","article-title":"Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK\/STAT3 axis","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"69","key":"10.1016\/j.intimp.2025.115405_bb0165","doi-asserted-by":"crossref","first-page":"113858","DOI":"10.18632\/oncotarget.23017","article-title":"Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:59:55Z","timestamp":1763697595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925013967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S1567576925013967"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115405","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piwi-interacting RNA-823 promotes cell growth and chemoresistance by stimulating the TGF-\u03b21-mediated AKT\/ERK pathway in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115405"}}